Anti-ERC1 monoclonal antibody

Pre-made anti-ERC1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ERC1/ERC1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2477-Ab-1/ GM-Tg-hg-IP2477-Ab-2Anti-Human ERC1 monoclonal antibodyHuman
GM-Tg-rg-IP2477-Ab-1/ GM-Tg-rg-IP2477-Ab-2Anti-Rat ERC1 monoclonal antibodyRat
GM-Tg-mg-IP2477-Ab-1/ GM-Tg-mg-IP2477-Ab-2Anti-Mouse ERC1 monoclonal antibodyMouse
GM-Tg-cynog-IP2477-Ab-1/ GM-Tg-cynog-IP2477-Ab-2Anti-Cynomolgus/ Rhesus macaque ERC1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2477-Ab-1/ GM-Tg-felg-IP2477-Ab-2Anti-Feline ERC1 monoclonal antibodyFeline
GM-Tg-cang-IP2477-Ab-1/ GM-Tg-cang-IP2477-Ab-2Anti-Canine ERC1 monoclonal antibodyCanine
GM-Tg-bovg-IP2477-Ab-1/ GM-Tg-bovg-IP2477-Ab-2Anti-Bovine ERC1 monoclonal antibodyBovine
GM-Tg-equg-IP2477-Ab-1/ GM-Tg-equg-IP2477-Ab-2Anti-Equine ERC1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2477-Ab-1/ GM-Tg-hg-IP2477-Ab-2; GM-Tg-rg-IP2477-Ab-1/ GM-Tg-rg-IP2477-Ab-2;
GM-Tg-mg-IP2477-Ab-1/ GM-Tg-mg-IP2477-Ab-2; GM-Tg-cynog-IP2477-Ab-1/ GM-Tg-cynog-IP2477-Ab-2;
GM-Tg-felg-IP2477-Ab-1/ GM-Tg-felg-IP2477-Ab-2; GM-Tg-cang-IP2477-Ab-1/ GM-Tg-cang-IP2477-Ab-2;
GM-Tg-bovg-IP2477-Ab-1/ GM-Tg-bovg-IP2477-Ab-2; GM-Tg-equg-IP2477-Ab-1/ GM-Tg-equg-IP2477-Ab-2
Products NameAnti-ERC1 monoclonal antibody
Formatmab
Target NameERC1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ERC1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2477-Ag-1Recombinant multi-species RB6I2/ ERC1/ Cast2 protein


    Target information

    Target IDGM-IP2477
    Target NameERC1
    Gene ID23085,111173,266806,707010,486753,101086319,519271,100050184
    Gene Symbol and Synonyms4930404L01Rik,5033405M01Rik,9630025C19Rik,B430107L16Rik,CAST,Cast2,ELKS,Elks1,ERC,ERC-1,ERC1,ERC1b,mKIAA1081,RAB6IP2,RAB6IP2A,RAB6IP2B
    Uniprot AccessionQ8IUD2,Q811U3
    Uniprot Entry NameRB6I2_HUMAN,RB6I2_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000082805
    Target ClassificationTumor-associated antigen (TAA)

    The target: ERC1, gene name: ERC1, also named as Cast2, ELKS, ERC-1, RAB6IP2. The protein encoded by this gene is a member of a family of RIM-binding proteins. RIMs are active zone proteins that regulate neurotransmitter release. This gene has been found fused to the receptor-type tyrosine kinase gene RET by gene rearrangement due to the translocation t(10;12)(q11;p13) in thyroid papillary carcinoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.